APA-viite

Guzauskas, G. F., Basu, A., Serbin, M., Carlson, J. J., & Veenstra, D. L. (2019). Are there different evidence thresholds for genomic vs. clinical precision medicine? A VOI-based framework applied to antiplatelet drug therapy. Value Health.

Chicago-tyylinen lähdeviittaus

Guzauskas, Gregory F., Anirban Basu, Michael Serbin, Josh J. Carlson, ja David L. Veenstra. "Are There Different Evidence Thresholds for Genomic Vs. Clinical Precision Medicine? A VOI-based Framework Applied to Antiplatelet Drug Therapy." Value Health 2019.

MLA-viite

Guzauskas, Gregory F., et al. "Are There Different Evidence Thresholds for Genomic Vs. Clinical Precision Medicine? A VOI-based Framework Applied to Antiplatelet Drug Therapy." Value Health 2019.

Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.